John Morris Moretz, a Director, acquired 549,475 Common Shares on an indirect ownership basis for registered holder Spouse at prices ranging from US$0.840 to US$0.847 between August 18th and 22nd, 2017. This represents a $584,423 investment into the company's shares and an account share holdings change of greater than 100%.
Neptune Tech & Biores is in the Biotechnology & Medical Research Sub Industry Group under the Healthcare Sector.
Neptune Technologies & Bioressources Inc. is a solution provider of omega-3's and other functional ingredients to branded marketers in the nutraceutical industry, primarily in North America. The Company is engaged in the development, manufacture and commercialization of marine-derived omega-3 fatty acids. The Company's products include Krill-Based Nutraceutical Products, including Neptune Krill Oil (NKO), OCEANO3, Formulations Derived from NKO and Neptune Krill Aquatein (NKA); Other Nutraceutical Products, and Pharmaceutical Product Candidate (CaPre)-Acasti. The Company's NKO is a marine oil extracted from krill (Euphasia superba). NKO consists of phospholipids, which contain omega-3 fatty acids, including eicosapentaenoic acid and docosahexaenoic acid (EPA & DHA), and antioxidants, such as astaxanthin, vitamin A and vitamin E. The Company sells OCEANO3 directly to consumers in Canada through its online platform (www.oceano3.com), under its brand name.
No Comments